Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loren K Mell

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2021
Trials and tribulations of bone marrow sparing radiotherapy for cervical cancer. Re: Zhou et al. Radiother Oncol. 2021;165:103-118Loren K Mell
International Journal of Radiation Oncology, Biology, Physics|September 19, 2015
Cultivating Future Clinician Scientists: In Regard to Vapiwala et alLoren K Mell
JAMA Otolaryngology-- Head & Neck Surgery|December 8, 2022
Problems With Interpreting Treatment Effects in Observational Competing Risks DataLoren K Mell
International Journal of Radiation Oncology, Biology, Physics|September 25, 2012
Intensity modulated radiation therapy for gynecologic malignancies: a testable hypothesisLoren K Mell
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference?Loren K Mell, Kaveh Zakeri
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2008
Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostineLoren K Mell, Benjamin Movsas
Gynecologic Oncology|August 2, 2003
Concern with "Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?"Loren K Mell, Arno J Mundt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2023
Good Radiosensitizer HuntingLoren K Mell, Stuart J Wong
Seminars in Radiation Oncology|March 16, 2025
Managing Patients with Head and Neck Cancer and Advanced Age or ComorbiditiesJames M Price, Loren K Mell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Pitfalls of using composite primary end points in the presence of competing risksLoren K Mell, Jong-Hyeon Jeong
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2021
Trials and tribulations of bone marrow sparing radiotherapy for cervical cancer. Re: Zhou et al. Radiother Oncol. 2021;165:103-118Loren K Mell
International Journal of Radiation Oncology, Biology, Physics|September 19, 2015
Cultivating Future Clinician Scientists: In Regard to Vapiwala et alLoren K Mell
JAMA Otolaryngology-- Head & Neck Surgery|December 8, 2022
Problems With Interpreting Treatment Effects in Observational Competing Risks DataLoren K Mell
International Journal of Radiation Oncology, Biology, Physics|September 25, 2012
Intensity modulated radiation therapy for gynecologic malignancies: a testable hypothesisLoren K Mell
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Underrepresentation of Local Therapy Trials in Leading Medical Journals: Cause for Outrage or Indifference?Loren K Mell, Kaveh Zakeri
Expert Opinion on Drug Metabolism & Toxicology|September 19, 2008
Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostineLoren K Mell, Benjamin Movsas
Gynecologic Oncology|August 2, 2003
Concern with "Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?"Loren K Mell, Arno J Mundt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2023
Good Radiosensitizer HuntingLoren K Mell, Stuart J Wong
Seminars in Radiation Oncology|March 16, 2025
Managing Patients with Head and Neck Cancer and Advanced Age or ComorbiditiesJames M Price, Loren K Mell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Pitfalls of using composite primary end points in the presence of competing risksLoren K Mell, Jong-Hyeon Jeong
Pageof 19